Choroidal melanoma patient views on the importance of treatment characteristics and outcomes, and physicians&apos; information provision in the Netherlands

Ocular OncologySurgery and Intervention

Inadvertent Scleral Perforation During Choroidal Melanoma Surgeries: Incidence, Risk Factors, Management, and Outcomes: Scleral Perforation in Melanoma Surgery

Am J Ophthalmol

Chou HD, Heimann H, Damato BE, Hussain RN

doi: 10.1016/j.ajo.2025.05.043

Retinal Diseases

Clinical characteristics associated with complications and poor visual outcomes in ocular toxoplasmosis: Analysis of 853 patients: complications and visual outcomes in ocular toxoplasmosis

Am J Ophthalmol

de-la-Torre A, Mejía-Salgado G, Cifuentes-González C, Cuevas M, García S, Rangel CM, Durán C, Pachón-Suárez DI, Bustamante-Arias A, Rojas-Carabali W

doi: 10.1016/j.ajo.2025.02.027

Ocular Oncology

Local tumour control and patient survival after ruthenium-106 brachytherapy for small choroidal melanoma

Br J Ophthalmol

Gallo B, Hussain R, Al-Jamal R, Khalid H, Stoker I, Hay G, Arora AK, Szlosarek PW, Sagoo MS

doi: 10.1136/bjo-2023-324687

Ocular Oncology

Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis

Surv Ophthalmol

Stålhammar G, Hagström A, Conradi ME, Williams PA

doi: 10.1016/j.survophthal.2024.09.004

Ocular Oncology

Long-term visual outcomes and side effects of ruthenium plaque brachytherapy in 310 eyes with small choroidal melanoma

Br J Ophthalmol

Gallo B, Hussain R, Al-Jamal R, Khalid H, Stoker I, Hay G, Arora AK, Sagoo MS

doi: 10.1136/bjo-2023-324686

Retinal Diseases

Aflibercept for central retinal vein occlusions: long-term outcomes of a 'Treat-and-Extend' regimen

BMJ Open Ophthalmol

Jaggi D, Nagamany T, Wolf S, Zinkernagel MS, Heussen FM

doi: 10.1136/bmjophth-2024-001659

Ocular Oncology

Performance of the MOLES and TFSOM-DIM scores in classifying choroidal nevi and melanoma

Sci Rep

Jahnke D, Grohmann C, Fuisting B, Skevas C, Spitzer MS, Birtel J

doi: 10.1038/s41598-024-78692-w

Macular Diseases

How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema

BMC Ophthalmol

Singh RP, Tabano D, Kuo BL, LaPrise A, Leng T, Kim E, Hatfield M, Garmo V

doi: 10.1186/s12886-024-03797-9

Macular Diseases

Adherence to Anti-VEGF Treatment in Patients with Neovascular Age-Related Macular Degeneration: A Real-World Study

Ophthalmol Ther

Shellvarajah M, Nguyen V, Steinmann S, Gillies MC, Sagkriotis A, Barthelmes D

doi: 10.1007/s40123-025-01140-z

Ophthalmology

Choroidal melanoma patient views on the importance of treatment characteristics and outcomes, and physicians' information provision in the Netherlands

Related content

Inadvertent Scleral Perforation During Choroidal Melanoma Surgeries: Incidence, Risk Factors, Management, and Outcomes: Scleral Perforation in Melanoma Surgery

Clinical characteristics associated with complications and poor visual outcomes in ocular toxoplasmosis: Analysis of 853 patients: complications and visual outcomes in ocular toxoplasmosis

Local tumour control and patient survival after ruthenium-106 brachytherapy for small choroidal melanoma

Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis

Long-term visual outcomes and side effects of ruthenium plaque brachytherapy in 310 eyes with small choroidal melanoma

Aflibercept for central retinal vein occlusions: long-term outcomes of a 'Treat-and-Extend' regimen

Performance of the MOLES and TFSOM-DIM scores in classifying choroidal nevi and melanoma

How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema

Adherence to Anti-VEGF Treatment in Patients with Neovascular Age-Related Macular Degeneration: A Real-World Study